UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2020 or [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 (Exact name of registrant as specified in its charter) | Delaware | 20-5313323 | | --- | --- | | (State or other jurisdiction of | (I.R.S. Employer | | incorporation or organization ...

Xtant Medical Holdings, Inc. (NYSE:XTNT) Q2 2020 Results Earnings Conference Call August 3, 2020 4:30 PM ET Company Participants Matt Steinberg - Investor Relations, Associate Vice President at Lazar FINN Partners Sean Browne - President, Chief Executive Officer Greg Jensen - Vice President of Finance, Chief Financial Officer Conference Call Participants Operator Greetings and welcome to Xtant Medical second quarter 2020 financial results conference call. At this time, all participants are in a listen-only ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2020 or [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ___________ to ___________ Commission File Number: 001-34951 XTANT MEDICAL HOLDINGS, INC. (Exact name of registrant as specified in its charter) | Delaware ...

Xtant Medical Holdings, Inc. (NYSE:XTNT) Q1 2020 Earnings Conference Call May 7, 2020 9:00 AM ET Company Participants David Carey - Lazar FINN Partners Sean Browne - President and CEO Greg Jensen - Vice President, Finance and CFO Conference Call Participants Operator Greetings and welcome to Xtant Medical First Quarter 2020 Financial Results Conference Call. At this time, all participants are in listen-only mode. [Operator Instructions] As a reminder, this conference is being recorded. I would now like to t ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2020 or [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ___________ to ___________ Commission File Number: 001-34951 XTANT MEDICAL HOLDINGS, INC. (Exact name of registrant as specified in its charter) | Delawar ...

Xtant Medical Holdings, Inc. (NYSE:XTNT) Q4 2019 Earnings Conference Call March 5, 2020 9:00 AM ET Company Participants David Carey - Lazar FINN Partners Sean Browne - President & Chief Executive Officer Greg Jensen - Vice President-Finance & Chief Financial Officer Conference Call Participants Operator Welcome to Xtant Medical's Fourth Quarter and Full Year 2019 Financial Results Conference Call. At this time, all participants are in listen-only mode. [Operator Instructions] As a reminder, this conference ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-K (Mark One) [X] ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2019 or [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from __________ to __________ Commission file number: 001-34951 Xtant Medical Holdings, Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware 20-531332 ...

Xtant Medical Holdings, Inc. (NYSE:XTNT) Q3 2019 Earnings Conference Call November 7, 2019 9:00 AM ET Company Participants David Carey – Lazar FINN Partners Sean Browne – President and Chief Executive Officer Greg Jensen – Vice President-Finance and Chief Financial Officer Conference Call Participants Operator Greetings, and welcome to the Xtant Medical Third Quarter 2019 Financial Results Conference Call. At this time all participants are in listen-only mode. [Operator Instructions] As a reminder, this con ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2019 or [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ___________ to ___________ Commission File Number: 001-34951 XTANT MEDICAL HOLDINGS, INC. (Exact name of registrant as specified in its charter) | Del ...

Xtant Medical Holdings, Inc. (NYSE:XTNT) Q2 2019 Earnings Conference Call August 8, 2019 9:00 AM ET Company Participants David Carey - MD, IR Greg Jensen - VP, Finance & CFO Conference Call Participants Operator Greetings, and welcome to the Xtant Medical Second Quarter 2019 Financial Results Conference Call. At this time all participants are in a listen-only mode. [Operator Instructions] As a reminder, this conference is being recorded. I would now like to turn the conference over to David Carey of Lazar P ...